Skip to main content
Premium Trial:

Request an Annual Quote

GE Healthcare Expands High-Content Screening Offerings with Two Pacts

NEW YORK (GenomeWeb News) – GE Healthcare has signed agreements with two separate firms intended to expand its offerings in the high-content cell screening field, the firm announced today.
 
The first pact is with Process Analysis and Automation, under which PAA will provide automated hardware and software for GE Healthcare’s IN Cell Analyzer and LEADseeker platforms.
 
Through the second agreement, with MatriCal, GE Healthcare will now be able to offer 96-well and 384-well, flat glass-bottom microwell plates “at a competitive rate.” GE said MatriCal’s plates provide low autofluorescence, evenness of plate surface, and optimum optical viewing surface for cell-based assays.
 
GE announced the alliances at the CHI High Content Analysis meeting taking place this week in San Francisco.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.